BioHarvest Sciences Inc. Common Stock (NASDAQ:BHST) — Market Cap & Net Worth
Market Cap & Net Worth: BioHarvest Sciences Inc. Common Stock (BHST)
BioHarvest Sciences Inc. Common Stock (NASDAQ:BHST) has a market capitalization of $72.31 Million ($72.31 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20565 globally and #4595 in its home market, demonstrating a 6.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioHarvest Sciences Inc. Common Stock's stock price $3.31 by its total outstanding shares 22667842 (22.67 Million). Review BHST total debt and obligations to assess the company's total debt and financial obligations.
BioHarvest Sciences Inc. Common Stock Market Cap History: 2026 to 2026
BioHarvest Sciences Inc. Common Stock's market capitalization history from 2026 to 2026. Data shows growth from $75.03 Million to $75.03 Million (0.00% CAGR).
BioHarvest Sciences Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioHarvest Sciences Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BHST by Market Capitalization
Companies near BioHarvest Sciences Inc. Common Stock in the global market cap rankings as of June 17, 2026.
Key companies related to BioHarvest Sciences Inc. Common Stock by market ranking:
- Nestlé S.A (F:NESM): Ranked #88 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #97 globally with a market cap of $204.31 Billion USD ( CHF161.60 Billion CHF).
- Danone SA (PA:BN): Ranked #549 globally with a market cap of $49.84 Billion USD ( €42.63 Billion EUR).
- Danone SA (F:BSND): Ranked #709 globally with a market cap of $39.05 Billion USD ( €33.40 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Nestlé S.A | F:NESM | $224.33 Billion | €85.00 |
| #97 | Nestle S.A. | SW:NESN | $204.31 Billion | CHF79.58 |
| #549 | Danone SA | PA:BN | $49.84 Billion | €66.20 |
| #709 | Danone SA | F:BSND | $39.05 Billion | €13.70 |
BioHarvest Sciences Inc. Common Stock Historical Marketcap From 2026 to 2026
Between 2026 and today, BioHarvest Sciences Inc. Common Stock's market cap moved from $75.03 Million to $ 75.03 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $75.03 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of BioHarvest Sciences Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $72.31 Million USD |
| MoneyControl | $72.31 Million USD |
| MarketWatch | $72.31 Million USD |
| marketcap.company | $72.31 Million USD |
| Reuters | $72.31 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and w… Read more